Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

... sale of CTI's remaining interest in a 50/50-owned joint venture with Spectrum Pharmaceuticals, Inc. in ... Gain on sale of investment in joint venture - - (10,244) ... Equity loss from investment in joint venture - - (1,204) ...

CuraGen Reports Second Quarter 2009 Financial Results

... materials with the SEC, including a definitive joint proxy statement/prospectus (the "Joint Proxy ... and Celldex have already filed a preliminary joint proxy statement/prospectus with the SEC on June 26, 2009. This joint proxy statement/prospectus is only a preliminary ...

TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction

... statement on Form S-4 that contains a joint proxy statement/prospectus with the SEC. ... of Raptor and TorreyPines are urged to read the joint proxy statement/prospectus to be included in a ... stockholders will be able to obtain a copy of the joint proxy statement/prospectus, as well as other ...

BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol

... (Nasdaq: VRNM ) today announced that its 50-50 joint venture company will operate under the name ... be pleased and enthusiastic with the progress our joint venture - Vercipia - has made in only a few short ... Since announcing the formation of the joint venture company in February, Vercipia has applied ...

Schering-Plough Reports Financial Results for 2009 Second Quarter

... quarter. Net sales of the cholesterol joint venture with Merck & Co., Inc., which include ... does not record sales of its cholesterol joint venture with Merck as the venture is accounted ... an assumed 50 percent of the global cholesterol joint venture net sales, Schering-Plough's adjusted net ...

NIH funds support UAB joint replacement research

... to improve the performance and longevity of total joint replacement components. The broadened UAB ... Research Partnership (BRP) in Total joint Replacements, will explore next-generation technology to improve the service life of total joint replacements, which UAB researchers believe could ...

Cadila Pharmaceuticals Launches Joint Venture With Novavax in India

... today announced the launch of their joint venture in India under the agreement signed between the two companies in March 2009. This joint venture, called CPL Biologicals Pvt. Ltd., will ... Modi, Chairman of CPL Biologicals, noted: "This joint venture represents an important strategic ...

Verenium Completes Amendment to 8% Senior Convertible Notes

... "This along with the recent news that our joint venture with our partner BP has been selected to ... for next-generation biofuels. Through a joint venture with BP, the Company is moving rapidly to ... to enter into and/or maintain collaboration and joint venture agreements and licenses, changes in the ....

New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives

... from pain (79 percent), fatigue (67 percent) and joint stiffness (57 percent) on a regular basis despite ... said that their treatment reduces the amount of joint pain and swelling and 71 percent feel that their ... is a progressive disease, it can cause permanent joint deformity and severe disability if not diagnosed ...

Caprion Proteomics Inc. and Applied Bioystems Work Together to Accelerate Protein Biomarker Verification and Validation

... Applied Biosystems/MDS Analytical Technologies joint venture, enables integrated quantitative and ... differentiate by antibody techniques. This joint effort is another example of both companies ... Applied Biosystems/MDS Analytical Technologies, a joint venture between Applied Biosystems LLC and MDS ...

Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD

... was expanded in August 2006 to include the joint development and commercialization of a fixed-dose ... the two companies announced an agreement for the joint worldwide development and marketing of a new ... and Novartis announced an agreement for the joint worldwide development and commercialization of a ...

Onyx Pharmaceuticals Files Complaint Against Bayer Corporation

... to Phase 2 Anti-Cancer Compound Discovered During joint Research EMERYVILLE, Calif., May 17 ... a Phase 2 anti-cancer compound discovered during joint research between Onyx and Bayer. In its ... research collaboration period by the companies' joint research teams. Discussions with Bayer regarding ...

WellGen, Inc. Launches Te Ame(TM) Nutritional Supplements With Proven Health Benefits of Proprietary Black Tea Extract

... Management, Supports Natural Immune Function and joint Health NORTH BRUNSWICK, N.J., May 13 ... in the areas of exercise recovery, immunity, joint health and stress management. (Photo: ... many different wellness challenges. Te Ame(TM) joint Care contains WellGen(R) theaflavin-enriched ...

REG Signs Agreement with Three Biodiesel Plants to Consolidate

... and Central Iowa Energy are urged to read the joint proxy statement/prospectus that will be contained ... Central Iowa Energy may obtain free copies of the joint proxy statement/prospectus and the other relevant ... and may also obtain free copies of the joint proxy statement/prospectus (when it becomes ...

The first DFG research centers to be funded for another 4 years

... another four years. This decision was made by the joint Committee of the Deutsche Forschungsgemeinschaft ... from Germany and abroad had already done, the joint Committee of the DFG has, by way of its approval, ... Professor Matthias Kleiner following the joint Committee's decision. Kleiner recalled that the ...

Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities

... 2009 of a partnership agreement to establish a joint venture to develop and commercialize products ... Neurobionix division. The objective of this joint venture is to bring to market Victhom's ... of gait disorders (e.g., foot drop). This joint venture intends to combine Victhom's unique ...

The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers

... foot ulcers. The agreement includes joint work in support of potential remedies and to ... promote the growth of new blood vessels. The joint agreement outlines three areas of potential study ... publish technical and medical information from joint research and testing work. Education - ...

Verenium Announces Organizational Changes

... and the recent announcement of a commercial joint venture with BP, Verenium is now consolidating ... for next-generation biofuels. Through a joint venture with BP, the Company is moving rapidly to ... to enter into and/or maintain collaboration and joint venture agreements and licenses, changes in the ....

Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India

... joint Venture to be funded by Cadila Pharmaceuticals ... (Nasdaq: NVAX ) announced today it has formed a joint venture with Cadila Pharmaceuticals Ltd. ... and diagnostic products in India. The joint venture will develop and commercialize Novavax's ...

AutoImmune Inc. Reports 2008 Fourth Quarter and Year End Financial Results

... Ph.D. stated, "Product sales at Colloral LLC, our joint venture with Deseret Laboratories, Inc., were up ... 440,000 213,000 Minority interest in joint venture (5,000) (5,000) ... $147,000 Minority interest in joint venture 11,000 33,000 ...

Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results

... Zevalin sales prior to the establishment of the joint venture with Spectrum Pharmaceuticals, Inc. ... initial 50% interest in Zevalin to a 50/50 owned joint venture with Spectrum for $15 million in December ... sold the remaining 50% interest in the Zevalin joint venture to Spectrum for approximately $16.5 ...

Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million

... to sell its 50% ownership interest in the Zevalin joint venture to Spectrum Pharmaceuticals, Inc. ... for $18 million. CTI and Spectrum established a joint venture in December 2008 to develop and ... all of the Zevalin related assets to the joint venture and sold to Spectrum a 50% membership ...

Encouraging high-risk research: DFG approves funding for 2 new Reinhart Koselleck projects

... innovative and high-risk research projects. The joint Committee of Germany's largest research funding ... Kleiner, President of the DFG, during the DFG's joint Committee session. It was the second time that the joint Committee has approved funding under this ...

Cumberland Emerging Technologies and UT Research Foundation Sign License Agreement for New Technology

... ) The joint development project has received more than ... study the drug's efficacy in patients. The joint development project is a result of the 2006 ... Cumberland Emerging Technologies, Inc. is a joint initiative between Cumberland Pharmaceuticals ....

Isis Initiates Phase 1 Clinical Trial of SGLT2 Antisense Drug

... to treat a wide variety of diseases. Isis is a joint owner of Regulus Therapeutics Inc., a joint venture focused on the discovery, development and ... to Isis Pharmaceuticals and its subsidiaries and joint venture. Isis Pharmaceuticals is a ...

While Most Companies and Industries Struggled in 2008, LifeModeler, Inc. Used Unique Products to Post Aggressive Business Gains in All Areas

... the leading medical device makers of human joint replacements with a quicker, more complete method ... of adults each year cross that boundary where joint replacement surgeries are less a "want" than a ... CEO and founder, Shawn McGuan. Replacement joint development, and subsequent production, is a ...

Cell Therapeutics Targeting Potential Zevalin Label Expansion, Pixantrone and OPAXIO Drug Approvals to Grow Commercial Operations and Revenues in 2009

... Zevalin(R). In November CTI established a 50/50 joint venture with Spectrum Pharmaceuticals, ... non-Hodgkin's lymphoma. CTI and Spectrum have a joint venture for the sales, marketing and development ... 2, 2009. Formed RIT Oncology, LLC, a 50/50 joint venture with Spectrum, by contributing all assets ...

Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria

... by the DuPont Tate & Lyle Bio Products joint venture. Loudon, TN ... by the DuPont Tate & Lyle Bio Products joint venture. Zemea® is the first ... DuPont Tate & Lyle Bio Products is a joint venture between DuPont, a global science company, ...

Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria

... by the DuPont Tate & Lyle Bio Products joint venture. Loudon, TN ... by the DuPont Tate & Lyle Bio Products joint venture. Zemea® is the first ... DuPont Tate & Lyle Bio Products is a joint venture between DuPont, a global science company, ...

Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis

... to treat a wide variety of diseases. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and ... to Isis Pharmaceuticals and its subsidiaries and joint venture. Isis Pharmaceuticals is a ...

Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program

... -- Develop an E. coli vaccine for cattle (a joint effort of WSU, UW and the University of Idaho ). ... or waste. -- Develop a herpes vaccine (a joint effort of the Hutchinson Center, IDRI and UW). ... trials. -- Develop a syphilis vaccine (a joint effort of UW, IDRI and the University of ...

Bioamber announces world's first bio-based succinic acid plant: helping to reduce dependence on fossil fuels

... ARD are pleased to announce that their Bioamber joint venture has obtained the necessary permits and ... for the cosmetics industry, and WHEATOLEO, a joint venture with OLEON in the market for surfactants ... succinic acid and derivatives. Bioamber is a joint venture established between DNP Green Technology ...

SleepQuest Achieves Coveted Accreditation

... earned the highly valued accreditation from the joint Commission on the Accreditation of Health Care ... against a set of national standards by The joint Commission's home care service survey team," says ... executive director, Home Care Accreditation, The joint Commission. "Achieving accreditation demonstrates ...

Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug

... entered into an agreement to form a 50/50 owned joint venture, RIT Oncology LLC, to commercialize ... of certain revenue targets. The closing of the joint venture transaction is subject to the ... will be satisfied in order to consummate the joint venture transaction, the success of ...

Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission

... -- Shasta Regional Medical Center has earned the joint Commission's Gold Seal of Approval(TM). By demonstrating compliance with the joint Commission's national standards for health ... been awarded its full accreditation. The joint Commission conducted an unannounced, initial ...

Isis Reports Financial Results and Highlights for Third Quarter of 2008

... setting Regulus Therapeutics (microRNA joint Venture) -- Published research in Molecular and ... is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and ... its Ibis Biosciences subsidiary and its Regulus joint venture, and the therapeutic and commercial ...

Advanced Life Sciences Announces Third Quarter 2008 Financial Results

... interest in Sarawak Medichem Pharmaceuticals joint venture ... interest in Sarawak Medichem Pharmaceuticals joint venture ... interest in Sarawak Medichem Pharmaceuticals joint venture ...

Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models

... both clinical and radiographic indicators of joint inflammation and damage, including soft tissue ... and loss of function in the joint. The inflamed joint lining, called the synovium, releases enzymes that destroy bone and cartilage, causing the joint to lose its shape and alignment. This process can ...

One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study

... experienced sustained improvements in the joint and skin symptoms of active psoriatic ... an inflammation of a tendon, ligament or joint capsule insertion to the bone, and dactylitis, a ... chronic inflammatory arthropathy manifesting with joint pain and swelling that can lead ...

ACTEMRA(R) (tocilizumab) Studies to be Featured at American College of Rheumatology Annual Scientific Meeting

... session], "Tocilizumab Inhibits Structural joint Damage in RA Patients with an Inadequate ... of ACTEMRA on the inhibition of structural joint damage in 2009. ACTEMRA is under review in the ... in the joints. This inflammation causes a loss of joint shape and function, resulting in pain, stiffness ...